Authors/Disclosures
|
Sandra Reiter-Campeau, MD
(Mayo Clinic)
|
Dr. Reiter-Campeau has nothing to disclose. |
|
|
No disclosure on file |
|
Olivier Fortin, MD
(Children's National Hospital)
|
Dr. Fortin has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Canadian Residency Matching Service. Dr. Fortin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Fédération des médecins résidents du Québec. Dr. Fortin has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Fédération des médecins résidents du Québec. Dr. Fortin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Association of residents of McGill. |
|
Olubunmi A. Ogunrin, MD
(University of Benin)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Chrispine Oduor
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Anne Lortie, MD
|
No disclosure on file |
|
Philippe Major, MD
(CHU Ste-Justine PO SA178275-D)
|
Dr. Major has nothing to disclose. |
|
|
No disclosure on file |
|
Ala P. Birca, MD
|
No disclosure on file |
|
Lionel Carmant, MD
(CHU Sainte-Justine)
|
No disclosure on file |
|
Kevin N. Sheth, MD, FAAN
(Yale UniversityDivision of Neuro and Critical Care)
|
Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |